Mar. 20 at 12:18 PM
$BLGO
Have the built a battery factory yet?
Have they sold a second PFAS system?
Have they resolved the licensing around POOPH, their main revenue source?
🫣😳😳😳😳😳😳😳
And I LOVE that they list “cash flow from financing activities” as a highlight.
More shares! More debt!
Financial highlights
●
Assets at December 31, 2025, were
$8,311,000, versus
$6,785,000 in liabilities, which included
$3,883,000 in cash and cash equivalents
●
Revenues for 2025 were
$7,765,000, versus
$17,779,000 in 2024 – engineering services revenues from third parties increased from
$1,017,000 to
$1,998,000
●
Net loss in 2025 was
$15,189,000, versus
$4,347,000 in 2024
●
Cash flow from financing activities was
$2,051,000 for BioLargo Inc.,
$5,745,000 for Clyra Medical, and
$425,000 for BioLargo Energy